申请人:Beaulieu Pierre
公开号:US20120101091A1
公开(公告)日:2012-04-26
The present application provides compounds of formula I wherein X, Y, R
2
, n, R
5
and R
6
are defined herein, useful as inhibitors of the hepatitis C virus NS5B polymerase The present application also provides pharmaceutical compositions containing said compounds, methods of using said compounds as pharmaceuticals alone or with other antiviral agent in the treatment of a hepatitis C viral infection in a mammal having or at risk of having the infection.